|
Market Closed -
Euronext Paris
11:55:00 2026-11-06 EST
|
Pre-market 02:03:15 | |||
| 27.00 EUR | -1.03% |
|
27.38 | +1.41% |
| 10-26 | Analysts unanimous after Nanobiotix's NBTXR3 results |  |
| 10-26 | Nanobiotix unveils encouraging results in the treatment of advanced melanoma | |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.03% | -3.98% | +31.58% | -19.31% | +38.46% | +58.64% | +397.24% | +204.91% | +103.31% | 1.53B | |
| -4.83% | +3.51% | -9.26% | -5.05% | +62.18% | +55.00% | +62.02% | +19.61% | - | 66.7B | |
| +0.02% | +1.07% | +15.62% | +6.89% | +13.81% | +11.72% | +74.73% | +198.17% | +6,084.99% | 56.88B | |
| -1.34% | +2.98% | +17.75% | +15.94% | +23.35% | +25.08% | +98.39% | -7.19% | +266.72% | 56.53B | |
| +5.09% | +9.89% | +16.23% | +16.85% | +33.95% | +27.19% | +103.27% | +16.33% | +1,148.34% | 46.49B | |
| +2.62% | +1.68% | +5.00% | +13.88% | +20.59% | +29.16% | +36.08% | +8.08% | +257.95% | 44.8B | |
| +8.24% | +0.51% | +2.21% | -6.27% | +141.41% | +215.16% | +807.84% | +487.47% | - | 41.59B | |
| -1.86% | +10.13% | +17.48% | +5.87% | +22.40% | +28.14% | +53.61% | +30.28% | +178.28% | 35.35B | |
| -2.97% | -9.84% | +49.70% | +76.44% | +74.00% | +90.91% | +61.94% | +17.18% | +200.43% | 33.29B | |
| +5.19% | +1.62% | +13.86% | -12.73% | -34.27% | -39.69% | +381.71% | +248.48% | +844.72% | 25.1B | |
| +2.81% | +9.87% | -9.01% | +6.24% | +55.85% | +43.44% | -2.78% | -52.24% | - | 24.92B | |
| +1.92% | -0.75% | -4.94% | -6.58% | -8.08% | -15.15% | -12.16% | -63.93% | - | 21.7B | |
| +2.86% | +0.17% | +8.36% | +10.57% | +16.28% | +10.86% | +137.18% | +190.84% | +1,925.15% | 18.27B | |
| +1.25% | +0.26% | +17.88% | +28.67% | +58.73% | +70.47% | +235.44% | +270.84% | +457.90% | 16.98B | |
| -0.45% | +1.05% | +17.09% | +26.99% | +42.05% | +52.09% | +73.94% | -13.29% | +119.68% | 16.88B | |
| +1.33% | +2.21% | +15.33% | +0.55% | - | - | - | - | - | 16.87B | |
| +7.83% | -6.09% | +13.26% | +26.18% | +69.20% | +100.84% | +91.81% | -9.72% | +368.13% | 16.17B | |
| +7.17% | +6.72% | +6.28% | +2.42% | +199.74% | +181.19% | +320.83% | +1,495.28% | +801.08% | 16.05B | |
| +1.53% | -3.13% | +24.46% | +24.45% | +12.36% | +28.65% | -20.64% | -23.62% | +162.59% | 15.34B | |
| +7.98% | +5.30% | +9.77% | +46.11% | +28.79% | +6.27% | - | - | - | 13.87B | |
| Average | +2.17% | +1.63% | +12.93% | +12.91% | +45.83% | +51.58% | +161.13% | +167.64% | +922.80% | 29.26B | |
| Weighted average by Cap. | +1.44% | +2.56% | +11.12% | +12.20% | +44.38% | +50.10% | +147.58% | +126.98% | +1,318.03% |
- Stock Market
- Stocks
- NANO Stock
- Sector Nanobiotix
Select your edition
All financial news and data tailored to specific country editions
